Free Trial

Advisors Capital Management LLC Sells 2,470 Shares of Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Advisors Capital Management cut its Synopsys stake by 29.4%, selling 2,470 shares and leaving 5,942 shares valued at $2,791,000 per its latest SEC filing.
  • Several brokerages lowered targets and ratings—consensus is a Hold with an average price target of $531, and firms including Morgan Stanley, Piper Sandler, Wells Fargo and HSBC trimmed price targets or outlooks.
  • Synopsys beat quarterly estimates with $3.77 EPS (vs. $3.56 expected) and $2.41B revenue (vs. $2.39B), with revenue up 65.6% YoY and FY2026 guidance set at $14.38–$14.46 EPS.
  • MarketBeat previews the top five stocks to own by May 1st.

Advisors Capital Management LLC decreased its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 29.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,942 shares of the semiconductor company's stock after selling 2,470 shares during the period. Advisors Capital Management LLC's holdings in Synopsys were worth $2,791,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Stanley Laman Group Ltd. grew its stake in Synopsys by 542.9% in the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company's stock worth $6,353,000 after purchasing an additional 10,874 shares during the period. Empirical Asset Management LLC bought a new position in Synopsys in the third quarter worth $773,000. Strategic Advisors LLC lifted its position in Synopsys by 76.3% during the third quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company's stock valued at $3,739,000 after buying an additional 3,279 shares during the period. China Universal Asset Management Co. Ltd. boosted its holdings in shares of Synopsys by 31.8% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company's stock valued at $6,957,000 after buying an additional 3,575 shares in the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd boosted its holdings in shares of Synopsys by 24.8% during the 3rd quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 23,970 shares of the semiconductor company's stock valued at $11,827,000 after buying an additional 4,759 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently issued reports on SNPS. Morgan Stanley reiterated an "equal weight" rating and issued a $480.00 price target (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Weiss Ratings reissued a "hold (c)" rating on shares of Synopsys in a research note on Thursday, January 22nd. Piper Sandler cut their price objective on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a report on Thursday, February 26th. Wells Fargo & Company decreased their target price on shares of Synopsys from $500.00 to $450.00 and set an "equal weight" rating for the company in a research note on Thursday, February 26th. Finally, HSBC lowered shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 target price for the company. in a report on Friday, February 20th. Eight investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Synopsys currently has a consensus rating of "Hold" and an average price target of $531.00.

Check Out Our Latest Analysis on SNPS

Synopsys Price Performance

SNPS opened at $498.54 on Tuesday. The firm has a market cap of $95.50 billion, a PE ratio of 77.41, a P/E/G ratio of 4.09 and a beta of 1.15. The stock has a 50-day moving average price of $427.25 and a 200-day moving average price of $444.89. Synopsys, Inc. has a 1 year low of $376.18 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating the consensus estimate of $3.56 by $0.21. The company had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. Synopsys's revenue for the quarter was up 65.6% on a year-over-year basis. During the same period in the prior year, the firm posted $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Sell-side analysts predict that Synopsys, Inc. will post 10.3 earnings per share for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines